GlassScriptPhysician profile
Bradley B Scheu
NPI 1427345099
$2,647.97
in general payments reported to CMS, 2019-2025
17 companies · $1,339 in 2025
The $1,339 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $123 · 2021: $748 · 2023: $56.84 · 2025: $1,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,226 · Food and Beverage: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,225.91 |
| Food and Beverage | $170.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midmark Corporation | $2,058.06 | 2021-2025 | |
| Glaxosmithkline, LLC. | $161.21 | 2019-2023 | Shingrix, Arexvy |
| Amgen INC. | $156.30 | 2019-2020 | |
| Novo Nordisk INC | $39.26 | 2019 | |
| Horizon Therapeutics Plc | $34.55 | 2019 | |
| Boston Scientific Corporation | $28.82 | 2021 | |
| Astellas Pharma US INC | $27.59 | 2019-2020 | |
| Lilly USA, LLC | $23.45 | 2019 | |
| Abbott Laboratories | $17.45 | 2019 | |
| Allergan, INC. | $17.12 | 2020 | |
| Merck Sharp & Dohme LLC | $13.02 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.48 | 2019 | |
| Abbvie INC. | $12.40 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.91 | 2020 | |
| Pfizer INC. | $11.89 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.67 | 2019 | |
| Arbor Pharmaceuticals, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Scheu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.